Meihua International Medical Technologies Co., Ltd.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $6.8M | $10.8M | $11.6M | $6.2M | $20.9M | $19.0M | $15.4M |
| Depreciation & Amortization | — | — | — | $541.3K | $595.5K | $497.2K | $481.1K |
| Depreciation | $534.0K | $543.7K | $408.2K | $541.3K | $595.5K | $497.2K | $481.1K |
| Amortization | $15.5K | $27.0K | $62.1K | $22.2K | $27.0K | $26.2K | $28.2K |
| Stock-Based Compensation | — | — | — | — | — | — | — |
| Net Cash from Operating Activities | $569.9K | $14.6M | $2.3M | $-9.2M | $-54.7K | $5.3M | $9.3M |
| Investing Activities | |||||||
| Capital Expenditures | $15.6K | $133.6K | $1.2M | $2.7M | $850.2K | $3.8M | $266.7K |
| Business Acquisitions | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-20.1M | $-20.4M | $-12.5M | $-8.6M | $-833.8K | $-16.1M | $-8.9M |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Repurchases | — | $200.0K | — | — | — | — | — |
| Net Cash from Financing Activities | $17.2M | $6.2M | $706.1K | $37.2M | $1.9M | $1.7M | $923.8K |
| Net Change in Cash | $-2.1M | $362.1K | $-9.8M | $18.6M | $961.9K | $-8.8M | $1.2M |
| Free Cash Flow | $554.3K | $14.5M | $1.1M | $-11.9M | $-904.9K | $1.5M | $9.0M |